Moderna

Moderna Quick Ratio

Quick Ratio (Acid Test) of Moderna (MRNA) as of Nov 22, 2026.

Quick Ratio

-

Last updated:

Quick Ratio (Acid Test) of Moderna is 2026 - . Quick Ratio (Acid Test) of Moderna was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Moderna since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Moderna with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Moderna

All Key Metrics — Moderna